Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nano-capsules designed for diagnosing malignant tumors

  • Nano-capsules designed for diagnosing malignant tumours

  • Patterns of brain activity reorganize visual perception during eye movements

  • 'Pain sensing' gene discovery could help in development of new methods of pain relief

  • Special fats proven essential for brain growth

  • Earthquakes prove to be an unexpected help in interpreting brain activity of very premature babies

  • Can you see what I hear? Blind human echolocators use visual areas of the brain

  • Depression associated with 5-fold increased mortality risk in heart failure patients

  • Rates of re-hospitalization for patients with traumatic brain injury higher than previously reported

  • Parents are integral in stopping rise as teen e-cigarette usage triples

  •